[ACCESSWIRE]
LONDON, UK / ACCESSWIRE / August 26, 2016 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Healthcare sector. Companies recently under review include Vanc Pharma, NeutriSci Intl, Zecotek Photonics, and SQI Diagnostics. Get all of our free research reports by signing up at: http://www.activewallst.com/register/.
On Thursday, August 25th, 2016, the TSX Venture Composite index was up 1.57%, finishing the trading session at 801.93. The TSX Composite Index, conversely, edged 0.03% higher, to finish at 14,630.72.
The Healthcare index ended the day at 87.61, 0.47% higher.
Active Wall St. has initiated reports on the following equities: Vanc Pharmaceuticals Inc. (TSX-V: NPH), NeutriSci International Inc. (TSX-V: NU), Zecotek Photonics Inc. (TSX-V: ZMS), and SQI Diagnostics Inc. (TSX-V: SQD). Register with us now for your free membership and research reports at: http://www.activewallst.com/register/.
Vanc Pharmaceuticals Inc. (TSX-V: NPH)
On Thursday, shares in Richmond, Canada headquartered Vanc Pharmaceuticals Inc. ended the session 6.67% lower at $0.21 with a total volume of 306,154 shares traded. Vanc Pharmaceuticals Inc.'s shares have declined 23.64% in the last one month. Shares of the company, which focuses on the manufacture and distribution of generic and over-the-counter pharmaceuticals, are trading below its 50-day and 200-day moving averages. The stock's 200-day moving average of $0.36 is greater than its 200-day moving average of $0.27. See our research report on NPH.V at: http://www.activewallst.com/registration-3/?symbol=NPH.
NeutriSci International Inc. (TSX-V: NU)
Calgary, Canada headquartered NeutriSci International Inc.'s stock finished Thursday's session 3.03% higher at $0.17 with a total volume of 185,000 shares traded. Over the previous three months and the past one year, shares of NeutriSci International, which researches, develops, and commercializes nutraceutical products, have gained 36.00% and 6.25%, respectively. However, the stock has lost 15.00% in the last one month. The Company's shares are trading above its 50-day and 200-day moving averages. NeutriSci International's 50-day moving average of $0.16 is above its 200-day moving average of $0.13. The complimentary research report on NU.V at: http://www.activewallst.com/registration-3/?symbol=NU.
Zecotek Photonics Inc. (TSX-V: ZMS)
Richmond, Canada headquartered Zecotek Photonics Inc.'s stock advanced 3.70%, to close the day at $0.28. The stock recorded a trading volume of 89,500 shares. Shares of Zecotek Photonics, which develops photonics technologies and products for use in commercial and research applications in industrial, scientific, and medical markets, have advanced 3.70% in the last one month. The company's shares are trading at their 50-day and 200-day moving averages of $0.28, respectively. Register for free and access the latest research report on ZMS.V at: http://www.activewallst.com/registration-3/?symbol=ZMS.
SQI Diagnostics Inc. (TSX-V: SQD)
On Thursday, shares in Toronto, Canada headquartered life sciences company, SQI Diagnostics Inc., recorded a trading volume of 188,000 shares, which was higher than their three months average volume of 59,150 shares. The stock ended the day 4.00% lower at $0.24. SQI Diagnostics Inc.'s stock has declined 20.00% in the last one month. Shares of the Company, which develops and commercializes proprietary technologies and products for advanced multiplexing diagnostics in Canada, are trading below its 50-day and 200-day moving averages. The stock's 200-day moving average of $0.31 is above its 50-day moving average of $0.27. Get free access to your research report on SQD.V at: http://www.activewallst.com/registration-3/?symbol=SQD.
Active Wall Street:
Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
AWS has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst, for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: [email protected]
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: Active Wall Street
